Csenge Advisory Group Evogene Ltd. Transaction History

Csenge Advisory Group

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$0.61 - $0.82 $6,100 - $8,200	-10,000 Reduced 32.51%	20,762 $13,000
Q3 2023 Nov 01, 2023	BUY	$0.58 - $1.41 $115 - $282	200 Added 0.65%	30,762 $18,000
Q2 2023 Jul 20, 2023	BUY	$0.56 - $1.2 $3,360 - $7,200	6,000 Added 24.43%	30,562 $32,000
Q1 2023 May 01, 2023	SELL	$0.59 - $0.86 $2,950 - $4,300	-5,000 Reduced 16.91%	24,562 $15,000
Q4 2022 Feb 10, 2023	SELL	$0.61 - $8.13 $1,464 - $19,512	-2,400 Reduced 7.51%	29,562 $20,000
Q2 2022 Jul 27, 2022	SELL	$0.75 - $1.33 $3,375 - $5,985	-4,500 Reduced 12.34%	31,962 $24,000
Q1 2022 May 09, 2022	BUY	$1.09 - $1.83 $8,460 - $14,204	7,762 Added 27.05%	36,462 $47,000
Q4 2021 Feb 10, 2022	SELL	$1.63 - $2.83 $9,780 - $16,980	-6,000 Reduced 17.29%	28,700 $96,000
Q3 2021 Oct 20, 2021	BUY	$2.45 - $3.45 $14,700 - $20,700	6,000 Added 20.91%	34,700 $91,000
Q2 2021 Jul 21, 2021	BUY	$3.3 - $5.02 $16,500 - $25,099	5,000 Added 21.1%	28,700 $96,000
Q1 2021 Apr 28, 2021	BUY	$4.29 - $9.94 $30,888 - $71,568	7,200 Added 43.64%	23,700 $110,000
Q4 2020 Jan 26, 2021	BUY	$2.41 - $5.63 $39,765 - $92,895	16,500 New	16,500 $78,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

Stay updated on Csenge Advisory Group with notifications on news.